Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate armodafinil as a wakefulness-promoting therapy as a
means of improving residual daytime sleepiness in patients with treated nocturia.